E‐cadherin‐Fc chimera protein matrix enhances cancer stem‐like properties and induces mesenchymal features in colon cancer cells. Issue 11 (30th September 2019)

• Record Type: Journal Article
• Authors: Qian, Yamin; Wu, Xin; Yokoyama, Yuhki; Okuzaki, Daisuke; Taguchi, Mai; Hirose, Haruka; Wang, Jiaqi; Hata, Tsuyoshi; Inoue, Akira; Hiraki, Masayuki; Ohtsuka, Masahisa; Takahashi, Hidekazu; Haraguchi, Naotsugu; Mizushima, Tsunekazu; Tanaka, Shinji; Mori, Masaki; Yamamoto, Hirofumi
• Is Part Of: Cancer science. Volume 110:Issue 11(2019)
• Page Start: 3520
• Page End: 3532
• Publication Date: 2019-09-30
• Subjects: cancer stem cell -- colon cancer -- E‐cadherin‐Fc -- epithelial‐mesenchymal transition -- extracellular matrix; Cancer -- Periodicals; Neoplasms -- Periodicals; Research -- Periodicals; Electronic journals; 616.994005
• DOI: 10.1111/cas.14193
• Languages: English
• ISSNs: 1347-9032

Abstract

Abstract: Cancer stem cells (CSC) are a subpopulation of tumor cells with properties of high tumorigenicity and drug resistance, which lead to recurrence and poor prognosis. Although a better understanding of CSC is essential for developing cancer therapies, scarcity of the CSC population has hindered such analyses. The aim of the present study was to elucidate whether the E‐cadherin‐Fc chimera protein (E‐cad‐Fc) enhances cancer stem‐like properties because studies show that soluble E‐cadherin stimulates human epithelial growth factor receptor (EGFR) and downstream signaling pathways that are reported to play a crucial role in CSC. For this purpose, we used ornithine decarboxylase (ODC)‐degron–transduced (Degron(+)) KM12SM cells as a CSC model that retains relatively low CSC properties. Compared to cultures without E‐cad‐Fc treatment, we found that E‐cad‐Fc treatment further suppressed proteasome activity and largely enhanced cancer stem‐like properties of ODC‐degron–transduced KM12SM cells. These results include increased expression of stem cell markers Lgr5, Bmi‐1, SOX9, CD44, and CD44v9, aldehyde dehydrogenase (ALDH), and enhancement of robust spheroid formation, and chemoresistance to 5‐fluorouracil (5‐FU) and oxaliplatin (L‐OHP). These effects could be attributed to activation of the EGFR pathway as identified by extensive phosphorylation of EGFR, ERK, PI3K, AKT, and mTOR. In SW480 cells, E‐cad‐Fc matrix induced some CSC markers such as CD44v9 and ALDH. We also found that E‐cad‐Fc matrix showed high efficiency of inducing mesenchymal changes in colon cancer cells. Our data suggest that the E‐cad‐Fc matrix may enhance CSC properties such as enhancement of chemoresistance and sphere formation. Abstract : E‐cadherin matrix induces epithelial‐mesenchymal transition in colon cancer. It also facilitates cancer stem‐like properties in ODC‐degron–transduced cells.